Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Celleration

Celleration?uq=oeHSfu7P
1999 FOUNDED
M&A STATUS
51-60 EMPLOYEES
M&A LATEST DEAL TYPE
$46.8M LATEST DEAL AMOUNT
Description

Developer of therapeutic ultrasound products for the wound care market. The company offers MIST Therapy System, a wound healing device that utilizes ultrasonic sound waves to heal wounds.

Formerly Known As
Advanced Medical Applications
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Parent Company
Primary Office
  • 6321 Bury Drive
  • Suite 15
  • Eden Prairie, MN 55346
  • United States

+1 (952) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Celleration’s full profile, request a free trial.

Celleration Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Jun-2015 $46.8M 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series AA) 04-Jan-2013 00.000 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 07-Jan-2011 000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 02-Jul-2008 0000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Nov-2005 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B2) 29-Jun-2004 $2.03M $2.03M 000.00 Completed Startup
1. Early Stage VC (Series A) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Celleration Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series AA 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series E 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 10,627,643 $0.010000 $0.07 $0.91 $0.91 1x $0.91 9.8%
Series A 133,333 $0.010000 $1.2 $1.47 $15 10x $1.47 0.12%
To view this company’s complete Cap Table, request access »

Celleration Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AAVIN Private Equity PE/Buyout Minority 000 0000 000000 0
Affinity Capital Management Venture Capital Minority 000 0000 000000 0
Baird Capital PE/Buyout Minority 000 0000 000000 0
CHV Capital Venture Capital Minority 000 0000 000000 0
CID Equity Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Celleration Executive Team (10)

Name Title Board
Seat
Contact
Info
Mark Wagner President & Chief Executive Officer
Christopher Geyen Chief Financial Officer
Fred Taft Area Director of Sales - Eastern US
Annette Plishka Area Director of Sales - Western US
Terri Grant Director, Marketing

1 Former Executive

You’re viewing 5 of 10 executives. Get the full list »